Adv Healthc Mater

Adv Healthc Mater

Country: Unknown

Publisher: Unknown

Publication Period: Unknown

30

Papers in Database

Journal Information
Publication Details
Additional Information

Subject Term Count: 1

Last Updated: Aug 05, 2025

Recent Papers

View All 30 Papers
Enzyme-Triggered Intestine-Specific Targeting Adhesive Platform for Universal Oral Drug Delivery.

Li Y, Lee JS, Kirtane AR, Li M, Coffey CW, Hess K, Lopes A, Collins J, Tamang S, Ishida K, Hayward …

2023 PMID: 37314859
3/7
COI Funding
New Strategy for Promoting Vascularization in Tumor Spheroids in a Microfluidic Assay.

Wan Z, Floryan MA, Coughlin MF, Zhang S, Zhong AX, Shelton SE, Wang X, Xu C, Barbie DA, Kamm RD.

2022 PMID: 36333913
3/7
COI Funding
COI Funding
Tissue Engineering Cartilage with Deep Zone Cytoarchitecture by High-Resolution Acoustic Cell Patterning.

Armstrong JPK, Pchelintseva E, Treumuth S, Campanella C, Meinert C, Klein TJ, Hutmacher DW, Drinkwa…

2022 PMID: 35815530
3/7
COI Funding
Tunable Microgel-Templated Porogel (MTP) Bioink for 3D Bioprinting Applications.

Ouyang L, Wojciechowski JP, Tang J, Guo Y, Stevens MM, Stevens MM.

2022 PMID: 35037731
4/7
Data COI Funding
3D Printed Porous Methacrylate/Silica Hybrid Scaffold for Bone Substitution.

Chung JJ, Yoo J, Sum BST, Li S, Lee S, Kim TH, Li Z, Stevens MM, Georgiou TK, Jung Y, Jones JR.

2021 PMID: 33951318
3/7
COI Funding
Ambient Temperature Stable, Scalable COVID-19 Polymer Particle Vaccines Induce Protective Immunity.

Chen S, Evert B, Adeniyi A, Salla-Martret M, Lua LH, Ozberk V, Pandey M, Good MF, Suhrbier A, Halfm…

2021 PMID: 34716678
3/7
COI Funding
A Modular Biomaterial Scaffold-Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS-CoV-2 Antigens.

Langellotto F, Dellacherie MO, Yeager C, Ijaz H, Yu J, Cheng CA, Dimitrakakis N, Seiler BT, Gebre M…

2021 PMID: 34605223
3/7
COI Funding
COI Funding
Effects of Mesenchymal Stem Cell-Derived Paracrine Signals and Their Delivery Strategies.

Chang C, Yan J, Yao Z, Zhang C, Li X, Mao HQ.

2021 PMID: 33433956
3/7
COI Funding